A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

Patients with Crohn's disease and long-term ileostomy experience endoscopic recurrence, with ileal involvement and prior ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

Crohn's disease is a serious inflammatory bowel disease (IBD) that impacts millions worldwide. The disease is chronic and ...

This event is more than just a gathering of incredible vehicles; it’s a meaningful day that brings together car enthusiasts, ...

US healthcare giant Johnson & Johnson announced that the prestigious medical journal The Lancet has published positive ...

AN award-winning guitarist and singer has cancelled his European tour dates on “doctor’s orders”. Laurence Jones, who has ...

Eli Lilly Canada Inc. (Lilly Canada) announced today that Health Canada has approved Omvoh® (mirikizumab) for CD, which will soon be available to patients in Canada. Omvoh® is an interleukin-23p19 ...

Health technology assessment (HTA) agency NICE has published final draft guidance for IL-23 inhibitor Omvoh (mirikizumab), ...

Lili Higgins spent more than a decade not knowing what was causing her persistent gut problems. From when she was just a baby ...

In a major advance for patients with Crohn’s disease, a new study led by researchers at Mount Sinai Health System found that guselkumab, a medication with a mechanism of action that is new to ...